Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesothelioma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesothelioma
Authors
Keywords
Mesothelioma, Malignant effusions, <em class=EmphasisTypeItalic >BAP1</em>, <em class=EmphasisTypeItalic >CDKN2A</em>, Patient derived tumor xenografts
Journal
BMC CANCER
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-05-07
DOI
10.1186/s12885-015-1362-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PIK3CA Mutation in Colorectal Cancer: Relationship with Genetic and Epigenetic Alterations
- (2015) Katsuhiko Nosho et al. NEOPLASIA
- AKT1 (E17K) Mutation in Pancreatic Cancer
- (2014) Azim Mohamedali et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Phenotypes and Karyotypes of Human Malignant Mesothelioma Cell Lines
- (2013) Vandana Relan et al. PLoS One
- Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma
- (2012) Yoshie Yoshikawa et al. CANCER SCIENCE
- Pathological and molecular biological approaches to early mesothelioma
- (2012) Tohru Tsujimura et al. International Journal of Clinical Oncology
- Immunotherapies for non-small-cell lung cancer and mesothelioma
- (2012) Anish Thomas et al. LANCET ONCOLOGY
- Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation
- (2011) L. Xi et al. BLOOD
- A Platform for Rapid Detection of Multiple Oncogenic Mutations With Relevance to Targeted Therapy in Non–Small-Cell Lung Cancer
- (2011) Zengliu Su et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- EGFR and KRAS mutation analysis in cytologic samples of lung adenocarcinoma enabled by laser capture microdissection
- (2011) Sinchita Roy Chowdhuri et al. MODERN PATHOLOGY
- The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
- (2011) Matthew Bott et al. NATURE GENETICS
- Germline BAP1 mutations predispose to malignant mesothelioma
- (2011) Joseph R Testa et al. NATURE GENETICS
- Losses of Both Products of the Cdkn2a/Arf Locus Contribute to Asbestos-Induced Mesothelioma Development and Cooperate to Accelerate Tumorigenesis
- (2011) Deborah A. Altomare et al. PLoS One
- FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesothelioma
- (2010) C. T.-S. Chung et al. JOURNAL OF CLINICAL PATHOLOGY
- BRCA1-Associated Protein-1 Is a Tumor Suppressor that Requires Deubiquitinating Activity and Nuclear Localization
- (2008) K. H. Ventii et al. CANCER RESEARCH
- Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing
- (2008) Jin Li et al. NATURE MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started